In a muscle-based version of in vitro motility assays, the unloaded shortening velocity of rabbit skeletal myofibrils has been determined in the presence and absence of affinity-column-purified polyclonal antibodies directed against the subfragment-2 region of myosin. Contraction was initiated by photohydrolysis of caged ATP and the time dependence of shortening was monitored by an inverted microscope equipped with a video camera. Antibody-treated myofibrils undergo unloaded shortening in a fast phase with initial rates and half-times comparable to control (untreated) myofibrils, despite a marked reduction in the isometric force of skinned muscle fibers in the presence of the antibodies. In antibodytreated myofibrils, this process is followed by a much slower phase of contraction, terminating in elongated structures with well-defined sarcomere spacings (-1 ,um) in contrast to the supercontracted globular state of control myofibrils. These results suggest that although the unloaded shortening of myofibrils (and in vitro motility of actin filaments over immobilized myosin heads) can be powered by myosin heads, the subfragment-2 region as well as the myosin head contributes to force production in actively contracting muscle.The classical rotating cross-bridge model proposes that the contractile force in activated muscle originates from a structural transition within the myosin head [subfragment-1 (S-1) subunit] while it is attached to actin (1, 2). The helix-coil model proposes that melting within subfragment-2 (S-2; the a-helical tail segment of heavy meromyosin) is triggered and generates force when the actin-attached cross-bridge swings away from the thick filament surface (3, 4). In earlier work (5), it was shown that purified anti-S-2 antibody can markedly depress the isometric tension generated by skinned psoas fibers. The reduction in tension (to about 7% ofcontrol fibers) occurs in the absence of any direct effect on the ability of S-1 to undergo cyclic interaction with actin as measured by the ATPase of antibody-treated fibers. One interpretation of this experiment is that S-2 contributes to force production in vivo, possibly through a helix-coil transition in the S-2 hinge domain of the myosin molecule (for review, see ref. 6). However, it seems clear from recent in vitro model studies that S-1 alone, energized by ATP, can produce force (7) and slide actin filaments at speeds approaching those obtained with muscle fibers under no-load conditions (8,9). One possibility to reconcile these observations is that the force generated by S-1 in the model systems is sufficient to produce sliding motion but not sufficient for the expression of the full isometric force developed in working muscle. To test this explanation, we have measured the relative unloaded sliding velocity of overlapping thin and thick filaments in myofibrils, the intact basic structural units of skeletal muscle, in the presence and absence of polyclonal antibodies directed against the S-2 region of myosin. In these experiments, we have...